SPINK1 and ovarian clear cell cancer: Studies have shown that targeting the autocrine IL-6 (interleukin-6)-SPINK1 (serine peptidase inhibitor Kazal type) signal axis can inhibit the metastasis and spread of ovarian clear cell carcinoma, which provides a possibility while replicating the therapy.